Related Experiment Videos
A sulfated proteoglycan as a novel ligand for CD44
N Toyama-Sorimachi1, M Miyasaka
1Department of Immunology, Tokyo Metropolitan Institute of Medical Science, Japan.
The Journal of Dermatology
|November 1, 1994
Summary
Researchers discovered a new CD44 ligand, a protein called gp600, which is involved in cell adhesion and metastasis. This finding sheds light on CD44
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- CD44 is a cell surface glycoprotein crucial for tumor metastasis and lymphocyte homing.
- Understanding CD44's interactions is key to developing targeted therapies.
Purpose of the Study:
- To identify novel ligands for CD44.
- To investigate the role of CD44 in cell adhesion and aggregation.
Main Methods:
- Transfection of mouse T cell line CTLL-2 with CD44 cDNA.
- Utilizing anti-CD44 monoclonal antibodies and hyaluronidase assays.
- Employing CD44-immunoglobulin chimeric proteins and biochemical analysis (sulfate labeling, chondroitinase digestion).
Main Results:
- CD44-transfected cells exhibited CD44-dependent aggregation, independent of hyaluronidase.
- A novel high-molecular-weight protein (gp600) was identified, binding specifically to CD44.
- gp600 contains chondroitin sulfate glycosaminoglycan chains, but CD44 did not bind to known forms of these molecules.
Conclusions:
- CD44 interacts with a novel chondroitin sulfate-containing ligand (gp600), not previously recognized.
- This interaction plays a role in CD44-mediated cell aggregation.
- Further research is needed to elucidate the specific structure of the glycosaminoglycan recognized by CD44.